How many stock units was Chemours director Erin Kane granted, and what is the significance of the $0.00 grant price?

Erin N. Kane was granted 7,182 stock units as board compensation, increasing her total holdings to 74,062.9086 units; the units were granted at $0.00 per unit, indicating they are a routine, non-cash equity award—not an open-market purchase—and will convert to common stock only upon her separation from the board.

What regulatory filing disclosed Erin Kane's stock unit grant, and what does it reveal about the nature of the transaction?

The insider transaction was reported on an SEC Form 4 filing, which confirms the grant is a routine, non-cash equity award for board service—not a market-based purchase—and that the units are subject to conversion into common stock only upon her separation from the board.

Chemours Director Erin Kane Granted 7,182 Stock Units

May 8, 2026

Chemours Co director Erin N. Kane received 7,182 stock units as board compensation, raising her total holdings to over 74,000 units. The routine non-cash equity award was disclosed via an SEC Form 4 filing.

Stock Titan

2026-05-08

Chemours Director Granted Equity Award

2026-05-08

Chemours Director Erin Kane Granted 7,182 Stock Units

2026-05-08

Chemours Director Granted 7,182 Company Shares

2026-05-21

Chemours Petitions NC Supreme Court to Dismiss AG Jackson's Lawsuit

2026-06-03

Chemours Honors 2026 Catalyst for Scientific Excellence Award Winners